NOK 14.0
(-6.35%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.29 NOK | -93.33% |
2022 | -0.15 NOK | 6.25% |
2021 | -0.16 NOK | -374.78% |
2020 | -0.03 NOK | 58.4% |
2019 | -0.08 NOK | 26.36% |
2018 | -0.11 NOK | -77.42% |
2017 | -0.06 NOK | 31.26% |
2016 | -0.09 NOK | 35.57% |
2015 | -0.14 NOK | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.09 NOK | -1128.99% |
2024 Q1 | -0.10 NOK | 13.45% |
2023 Q3 | -0.05 NOK | 27.27% |
2023 Q1 | -0.06 NOK | 25.34% |
2023 Q4 | -0.11 NOK | -118.25% |
2023 FY | - NOK | -93.33% |
2023 Q2 | -0.07 NOK | -25.09% |
2022 Q4 | -0.07 NOK | -4264.71% |
2022 Q2 | -0.02 NOK | 0.0% |
2022 FY | - NOK | 6.25% |
2022 Q3 | -0.00 NOK | 91.5% |
2021 FY | - NOK | -374.78% |
2020 FY | - NOK | 58.4% |
2019 FY | - NOK | 26.36% |
2018 FY | - NOK | -77.42% |
2017 FY | - NOK | 31.26% |
2016 FY | - NOK | 35.57% |
2015 FY | - NOK | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Gentian Diagnostics ASA | -0.69 NOK | 57.971% |
Medistim ASA | 5.68 NOK | 105.106% |